Skip NavigationMarketsBusinessInvestingTechPolitics & PolicyVideoWatchlistInvesting ClubPRO
LivestreamMenuProcter & Gamble could soon get a much-needed lift, according to Evercore ISI. The investment firm upgraded the household goods stock to outperform from in line. It also hiked its price target on shares to $166 from $161, implying nearly 14% upside from Monday’s close. “All interventions correcting gaps in Procter’s value equations are layered and working, with top-line and U.S. share lifts mechanically extending into [the fourth quarter of fiscal year 2027]… [and] Improvement beyond the interventions— high-margin Olay, Downy, Native, Dawn and Pantene now contribute more to growth than Pampers, where the Costco reentry and the upgraded mid-tier diaper face abating headwinds from Chinese diapers,” analyst Robert Ottenstein said Tuesday in a note to clients. Shares of Procter & Gamble have ticked up about 2% year to date, while the S & P 500 is up 14%, as higher tariffs and other costs have pressured its margins. The company has also contended with sluggish sales due to softer consumer demand and mounting competition. PG YTD mountain Shares have risen about 2% in 2026. However, Procter’s U.S. category volumes are stabilizing, gaining 40 basis points sequentially versus the June quarter, according to Evercore ISI. Ottenstein also noted that the company’s promotions are elevated but targeted, which means they should protect pricing. That should ultimately help boost Procter’s shares, he added. “Procter continues to lead price-mix, and the acceleration to 4.8% growth in September suggests that innovation, pricing and marketing are resonating,” he wrote. Evercore ISI’s call goes against consensus on Wall Street. Of the 27 analysts covering Procter & Gamble, just 11 have a buy or strong buy on the stock, while 15 have a hold rating on it, LSEG data shows. Shares rose more than 1% following the rating change.Read More














